logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 20 of 24 Items
Showing 1 - 20 of 24 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

‘I can change my life’: perceptions and experiences of people who use drugs engaging in medically assisted therapy in Kiambu County, Kenya

Burtscher D, Riitho W, Kariuki M, Thiong’o A, Ayuaya T,  et al.
2024-11-17 • Drugs: Education, Prevention and Policy
2024-11-17 • Drugs: Education, Prevention and Policy

INTRODUCTION

The Médecins Sans Frontières (MSF) Kiambu People Who Use Drugs (PWUD) project, which started in September 2019, had enrolled 590 PWUD in its Medica...

Conference Material
|
Poster

"I can change my life": Perceptions and experiences of people who use drugs engaging in medication assisted treatment in Kiambu County, Kenya

Burtscher D, Riitho W, Kariuki M, Thiong'o AW, Ayuaya T,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Journal Article
|
Research

Human mobility and health: Exploring the health conditions of Venezuelan migrants and refugees in Colombia

Cubides JC, Peiter PC, Garone DB, Antierens A
2021-10-26 • Journal of Immigrant and Minority Health
2021-10-26 • Journal of Immigrant and Minority Health
Médecins sans Frontières (MSF) conducted a study to identify health needs and access barriers of Venezuelan migrants and refugees at La Guajira and Norte de Santander Colombian border st...
Journal Article
|
Research

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Sissoko D, Laouenan C, Folkesson E, M’Lebing A, Beavogui A,  et al.
2016-03-01 • PLOS Medicine
2016-03-01 • PLOS Medicine
Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the World Health ...
Journal Article
|
Research

Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon

Christinet V, Rossel L, Serafini M, Delhumeau C, Odermatt P,  et al.
2014-04-26 • Open Forum Infectious Diseases
2014-04-26 • Open Forum Infectious Diseases
Abstract
Background.  Buruli ulcer is the third most common mycobacterial disease after tuberculosis and leprosy and is particularly f...
Journal Article
|
Commentary

Ensuring on-site Ebola patient monitoring and follow-up: development of a laboratory structure embedded in an Ebola treatment center

Williams A, Amand M, Van der Bergh R, Antierens A, Chaillet P
2019-06-24 • Disaster Medicine and Public Health Preparedness
2019-06-24 • Disaster Medicine and Public Health Preparedness
The capacity to rapidly distinguish Ebola virus disease from other infectious diseases and to monitor biochemistry and viremia levels is crucial to the clinical management of suspected E...
Journal Article
|
Research

Evaluation of convalescent plasma for Ebola Virus Disease in Guinea

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P,  et al.
2016-01-07 • New England Journal of Medicine
2016-01-07 • New England Journal of Medicine
BACKGROUND
In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with co...
Journal Article
|
Research

Impact of HIV on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon

Christinet V, Comte E, Ciaffi L, Odermatt P, Serafini M,  et al.
2014-05-21 • Open Forum Infectious Diseases
2014-05-21 • Open Forum Infectious Diseases
Background: Buruli ulcer (BU) is the third most common mycobacterial disease after tuberculosis and leprosy and is particularly frequent in rural West and Central Africa. However, the im...
Journal Article
|
Research

Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea

Van der Bergh R, Chaillet P, Sow MS, Amand M, van Vyve C,  et al.
2016-02-01 • Emerging Infectious Diseases
2016-02-01 • Emerging Infectious Diseases
Rapid diagnostic methods are essential in control of Ebola outbreaks and lead to timely isolation of cases and improved epidemiologic surveillance. Diagnosis during Ebola outbreaks in We...
Journal Article
|
Research

Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context?

Ververs MT, Antierens A, Sackl A, Staderini N, Captier V
2013-06-07 • PLoS Currents
2013-06-07 • PLoS Currents
Journal Article
|
Research

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S,  et al.
2015-01-19 • Nature Genetics
2015-01-19 • Nature Genetics
Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here w...
Conference Material
|
Poster

Outbreak of ESBL Klebsiella pneumoniae in a maternity unit in Central African Republic

Gil Cuesta J, Thallinger M, Antierens A, Caluwaerts A, Chaillet P,  et al.
2018-05-14 • MSF Scientific Days International 2018: Research
2018-05-14 • MSF Scientific Days International 2018: Research
Journal Article
|
Research

Ethics of emerging infectious disease outbreak responses: using Ebola virus disease as a case study of limited resource allocation

Nichol AA, Antierens A
2021-02-02 • PLOS One
2021-02-02 • PLOS One
Emerging infectious diseases such as Ebola Virus Disease (EVD), Nipah Virus Encephalitis and Lassa fever pose significant epidemic threats. Responses to emerging infectious disease outbr...
Conference Material
|
Slide Presentation

“Where my pocket can afford is where I will take my child:” the influence of structural factors on health-seeking behaviour, Sierra Leone

Burtscher D, Maukner AC, Piatti M, Verschuere J, Aruna TM,  et al.
2022-05-12 • MSF Scientific Days International 2022
2022-05-12 • MSF Scientific Days International 2022
Journal Article
|
Short Report

First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease

Dornemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H,  et al.
2017-01-15 • Journal of Infectious Diseases
2017-01-15 • Journal of Infectious Diseases
A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. The patient was treated with monoclonal antibodies (ZMapp), a buffy coa...
Journal Article
|
Research

Cholera in pregnancy: Outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti

Ciglenecki I, Bichet M, Tena J, Mondesir E, Bastard M,  et al.
2013-08-15 • PLOS Neglected Tropical Diseases
2013-08-15 • PLOS Neglected Tropical Diseases
BACKGROUND
The association between cholera in pregnancy and negative fetal outcome has been described since the 19th century. However, there is limited published literature on the su...
Journal Article
|
Commentary

Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: a case study in Guinea, West Africa

Carazo Perez S, Folkesson E, Anglaret X, Beavogui A, Berbain E,  et al.
2017-06-22 • PLOS Neglected Tropical Diseases
2017-06-22 • PLOS Neglected Tropical Diseases
During the large Ebola outbreak that affected West Africa in 2014 and 2015, studies were launched to evaluate potential treatments for the disease. A clinical trial to evaluate the effec...
Journal Article
|
Research

Experimental Treatment of Ebola Virus Disease with Brincidofovir

Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciqlenecki I,  et al.
2016-09-09 • PLOS One
2016-09-09 • PLOS One
The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against E...
Journal Article
|
Research

Description and predictive factors of individual outcomes in a refugee camp based mental health intervention (Beirut, Lebanon)

Bastin P, Bastard M, Rossel L, Melgar P, Jones A,  et al.
2013-01-17 • PLOS One
2013-01-17 • PLOS One
BACKGROUND
There is little evidence on the effectiveness of services for the care of people with mental disorders among refugee populations. Médecins sans Frontières (MSF) has establ...
Journal Article
|
Research

Low incidence of renal dysfunction among HIV-infected patients on a tenofovir-based first line antiretroviral treatment regimen in Myanmar

Kyaw NTT, Harries AD, Chinnakali P, Antierens A, Soe KT,  et al.
2015-08-24 • PLOS One
2015-08-24 • PLOS One
BACKGROUND
Since 2004, Médecins Sans Frontières-Switzerland has provided treatment and care for people living with HIV in Dawei, Myanmar. Renal function is routinely monitored in pat...